These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6696567)

  • 1. Effects of indoramin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Feb; 144(2):308-12. PubMed ID: 6696567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prazosin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Jun; 144(6):1196-200. PubMed ID: 6732379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propranolol therapy on renal function and body fluid composition.
    Bauer JH
    Arch Intern Med; 1983 May; 143(5):927-31. PubMed ID: 6679237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of guanabenz therapy on renal function and body fluid composition.
    Bauer JH
    Arch Intern Med; 1983 Jun; 143(6):1163-7. PubMed ID: 6860045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP; Bauer JH
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term nifedipine treatment on body fluid composition in essential hypertension.
    Toftdahl DB; Andersen GS
    J Hum Hypertens; 1989 Jun; 3(3):203-6. PubMed ID: 2769676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoramin in the treatment of hypertension. A mini-review and update.
    Archibald JL; Turner P
    S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic effects of indoramin on renal function, hemodynamics, and transport.
    Morrison G; Spar B; Walker BR; Goldfarb S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S25-9. PubMed ID: 2423792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
    Yajnik BH; Shah JS
    J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term trial of an alpha adrenoceptor blocking drug (Indoramin) in asthma. A preliminary report.
    Black JL; Temple DM; Anderson SD
    Scand J Respir Dis; 1978; 59(6):307-12. PubMed ID: 373090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoramin in the treatment of hypertension.
    Stannard M; Cohen M
    Practitioner; 1983 Oct; 227(1384):1601-5. PubMed ID: 6634630
    [No Abstract]   [Full Text] [Related]  

  • 19. Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.
    Stokes GS; Frost GW; Graham RM; MacCarthy EP
    Clin Pharmacol Ther; 1979 Jun; 25(6):783-9. PubMed ID: 36250
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute and long-term effects of modified hemoglobin (HBOC-201) in a rat model of hypertension and chronic kidney disease.
    Baylis C
    Transfusion; 2006 Jul; 46(7):1104-11. PubMed ID: 16836556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.